In this podcast, Brett M. Elicker, MD, and David E. Griffith, MD, ATSF, FACCP, FRSM, discuss the pathophysiology of non–cystic fibrosis bronchiectasis (NCFBE), the patient burden, and best practices with diagnosing NCFBE, including: The vicious vortex of NCFBE (ie, airway dysfunction, inflammation, infection) Cough as the most significant symptom and burden Imaging bronchiectasis with classic and inflammatory findings Differentiating the causes of NCFBE to inform patient care Presenters Brett M....
Jun 18, 2025•24 min•Ep. 103
Respiratory Syncytial Virus (RSV) significantly impacts adults, especially those over age 60 and those with chronic conditions. In this podcast, nurse practitioners Drs. Carrico and Stevenson discuss the underestimated burden of RSV. The podcast also explores practical strategies for increasing vaccine uptake that you can apply to your practice starting today so that you can protect your patients against RSV. Listen as they discuss: The Burden of Adult RSV RSV Vaccines for Adults: Data and Recom...
Jun 11, 2025•1 hr 7 min•Ep. 102
Listen in as Evette Whaley and Katie Smiley PA-C talk about innovative strategies for NPs and PAs to improve treatment for pediatric patients with atopic dermatitis. They discuss how to assess the whole patient and their family to better understand the impact of the disease on their quality of life. They also discuss newer treatments and how they can be incorporated into a comprehensive management plan for pediatric patients and their caregivers. Presenters: Evette Whaley Caregiver Baltimore, Ma...
May 27, 2025•22 min•Ep. 101
Listen in as rheumatology experts Alexis Ogdie, MD, MSCE, and Julia Swafford, PA-C, DFAAPA, discuss emerging therapies and strategies in managing patients with axial spondyloarthritis or psoriatic arthritis, including: The current treatment landscape (eg, small molecules, biologics) Risk factors to consider when prescribing JAK inhibitors Key considerations regarding comorbidities, especially in addressing depression, anxiety, or social ideation Nonpharmacologic options to improve treatment outc...
Jan 29, 2025•28 min•Ep. 100
In this episode, learn how early and sustained HBV care can be enhanced by expanding the role of primary care providers in HBV management. Learn how to: Engage key stakeholders in the provision of HBV care Provide HBV management resources to support PCPs who are doing screening Consider specialty and primary care collaborations that empower PCPs with clear guidance on how to manage patients living with HBV Presenters: Su Wang, MD, MPH, FACP Medical Director Center for Asian Health and Viral He...
Apr 26, 2024•19 min•Ep. 99
In this episode, Mark S. Sulkowski, MD, FIDSA, FAASLD; Tatyana Kushner, MD, MSCE; Paul Y. Kwo, MD; and patient advocate Jacki Chen, PhD, consider barriers and solutions for more expansive HBV treatment in the United States. Topics include: Patient subgroups to consider for treatment outside guideline criteria Adverse event and cost-effectiveness considerations Integration of patient perspectives in wider treatment Presenters: Mark S. Sulkowski, MD, FIDSA, FAASLD Professor of Medicine Director, D...
Mar 26, 2024•21 min•Ep. 98
In this episode, Arun B. Jesudian, MD, and Mazen Noureddin, MD, MHSc, discuss the expert-informed clinical pathway for the multidisciplinary care of patients with MASLD or MASH, current and emerging therapeutics, and management optimization strategies. Presenters: Arun B. Jesudian, MD Associate Professor of Clinical Medicine Division of Gastroenterology and Hepatology Weill Cornell Medicine New York, New York Mazen Noureddin, MD, MHSc Professor of Medicine Houston Methodist Hospital Director Hou...
Mar 13, 2024•30 min•Ep. 97
In this episode, Douglas Dieterich, MD, leads a panel discussion with Camilla S. Graham, MD, MPH, and Robert Wong, MD, MS, to consider advantages and barriers to universal screening for chronic HBV infection and universal HDV screening in adults with HBV in the United States. Topics include: Updated CDC recommendations for one-time universal screening for HBV Addressing patient-, provider-, and system-level barriers to universal HBV screening Best practices for implementation of HDV screening Pr...
Dec 22, 2023•28 min•Ep. 95
In this episode, Renslow Sherer, MD, and Trinh P. Vu, PharmD, BCIDP, discuss strategies for managing ambulatory patients with acute or previous COVID-19 infection, including: Current COVID-19 landscape Rapid antigen tests and PCR tests Risk stratification of patients who have a positive SARS-CoV-2 test Antiviral treatment (nirmatrelvir + ritonavir, remdesivir, and molnupiravir) Long COVID Presenters: Renslow Sherer, MD Director, International HIV Training Center Professor of Medicine Section of ...
May 03, 2023•1 hr 15 min•Ep. 93
In this episode, Jona Tanguay, MMSc, PA-C, AAHIVS discusses considerations to review with patients to empower them to make their own informed choices in PrEP selection, including: Leveraging PrEP options with unique dosing schedules and/or routes such as long-acting cabotegravir and on-demand 2-1-1 FTC/TDF Differences in adverse effect profiles between 4 PrEP options Potential for HIV resistance Requirements for compliance and monitoring Evidence in populations with various acquisition behaviors...
Apr 25, 2023•13 min•Ep. 90
In this episode, Dr. Battista and Dr. Parsons discuss the importance of care guidelines and the multidisciplinary team in the treatment of spinal muscular atrophy (SMA). This overview will include: The role each member of the interdisciplinary team plays in the care of SMA including physical therapists, occupational therapists, and speech therapists The importance of continued, ongoing therapy in addition to medication therapy to provide the greatest improvement in SMA care How to manage transit...
Apr 18, 2023•14 min•Ep. 86
In this episode, Julie Parsons, MD, discusses the genetic diagnosis of spinal muscular atrophy (SMA), anticipated clinical findings, the importance of newborn screenings, and the next steps to consider after a positive diagnosis is obtained. This high-level overview includes: SMA as an autosomal recessive disease Differences in spinal motor neurons (SMN) 1 and 2 at the time of diagnosis and how these drive severity of disease Important clinical findings in the diagnosis of SMA, as every child ma...
Apr 18, 2023•12 min•Ep. 84
In this episode, Dr. Parsons and Dr. Battista discuss current and emerging medical therapies for the treatment of spinal muscular atrophy (SMA). They review safety, efficacy, and monitoring parameters of current agents, as well as adjuct therapies in the medication pipeline. This high-level overview includes: Review of FDA-approved medical therapies: nusinersen, onasemnogene abeparvovec-xioi, and risdiplam Discussion of the safety, efficacy, and monitoring parameters for FDA approved medications...
Apr 18, 2023•12 min•Ep. 85
In this episode, Vikramjit Mukherjee, MD, and Cameron Smith, MPAS, PA-C, answer audience questions on how best to care for hospitalized patients with COVID-19 from a live, virtual question and answer webinar. This episode includes expert insights on: Viral coinfections such as influenza and RSV New data comparing baricitinib and tocilizumab for patients with severe COVID-19 Management of bacterial and fungal coinfection while incorporating antimicrobial stewardship Tips for transitioning patient...
Mar 27, 2023•15 min•Ep. 83
In this episode, Vikramjit Mukherjee, MD, and Cameron Smith, MPAS, PA-C, answer audience questions on how best to care for hospitalized patients with COVID-19 from a live, virtual question and answer webinar. This episode includes expert insights on: Supportive care management such as oxygen support, glycemic control, and anticoagulation Escalation of therapy in patients with worsening oxygen requirements Use of remdesivir in patients with renal dysfunction Brief commentary on long COVID Present...
Mar 27, 2023•20 min•Ep. 82
In this podcast, Susan LeLacheur, DrPH, PA-C, AAHIVS discusses racial disparities in access to HIV prevention (PrEP) and strategies to close these gaps, including: Incorporating comprehensive sexual history into medical appointments and offering PrEP to all sexually active patients Increase awareness of PrEP access programs in communities of color Diversification of the medical workforce Faculty: Susan LeLacheur, DrPH, PA-C, AAHIVS Professor Department of Physician Assistant Studies School of Me...
Jan 19, 2023•9 min•Ep. 78
This podcast episode is part of a multimedia program reviewing the management of nontuberculous mycobacterial lung disease (NTM-LD). Tune in to hear Jennifer Faber-Gerling, RN, MS, CNS, ANP-BC, and Anne O’Donnell, MD, highlight the diagnostic criteria and optimal treatment strategies in patients with NTM-LD. The overview will include: Recommended assessments and tests to appropriately diagnosis NTM-LD in patients A summary of the current guidelines for the management of NTM-LD, including appropr...
Jan 10, 2023•14 min•Ep. 74
In this episode, Tracy Zivin-Tutela, MD, answers audience questions on how best to care for patients at high risk of complications due to influenza from a live virtual meeting series. This episode includes expert insights on: Emerging resistance patterns of currently used antivirals Getting the flu vaccine after treatment with antivirals Use of antivirals in patients who test positive for flu and COVID-19 Techniques and over-the-counter therapies other than yearly vaccination to avoid severe com...
Jan 09, 2023•15 min•Ep. 77
In this episode, Stephen Krieger, MD, and Allison Boyd, MPAS, PA-C, MSCSdiscuss timely recognition of MS, including insights into why early recognition can lead to early treatment, which can decrease the risk of disability progression and produces better outcomes. Challenges discussed include the variable clinical presentation of MS and the lack of specific tests. The experts also discuss how to avoid missed diagnosis and misdiagnosis. Stephen Krieger, MD: consultant/advisor/speaker: Biogen, EMD...
Dec 30, 2022•18 min•Ep. 75
In this episode, Stephen Krieger, MD, and Allison Boyd, MPAS, PA-C, MSCSdiscuss the expanding treatment armamentarium for MS, the complexities involved in making treatment selection, patient factors to consider when individualizing treatment, and how best to talk with patients about their options within the context of shared decision-making. Stephen Krieger, MD: consultant/advisor/speaker: Biogen, EMD Serono, Genentech, Genzyme/Sanofi, Novartis, Octave, TG Therapeutics; researcher: Biogen, Brist...
Dec 30, 2022•17 min•Ep. 76
In this episode, Stephen Krieger, MD, and Allison Boyd, MPAS, PA-C, MSCS discuss the challenges of managing patients with MS over the long-term, including assessment and management of comorbidities management, differentiating relapse from pseudorelapse, telemedicine, and the important role of NPs and PAs in multidisciplinary care.
Dec 28, 2022•17 min•Ep. 73
In this podcast, Jason E. Farley, PhD, MPH, ANP-BC shares his recommendations on the best ways to implement new HIV PrEP guidelines based on his clinical experiences.
Nov 15, 2022•10 min•Ep. 72
In this podcast, Latesha Elopre, MD, MSPH, discusses how the new CDC recommendations on pre-exposure prophylaxis (PrEP) education, eligibility, and monitoring affect her clinical practice. Contributors: Latesha Elopre, MD, MSPH Associate Professor Division of Infectious Diseases University of Alabama at Birmingham Birmingham, Alabama Latesha Elopre, MD, MSPH, has no relevant financial relationships to disclose....
Aug 09, 2022•6 min•Ep. 71
In this podcast, Latesha Elopre, MD, MSPH and Jason Farley, PhD, MPH, ANP-BC, FAAN, AACRN answer pressing questions from healthcare professionals who care for patients that may be at risk for HIV infection. Presenters: Latesha Elopre, MD, MSPH Associate Professor Division of Infectious Diseases University of Alabama at Birmingham Birmingham, Alabama Moderator Jason Farley, PhD, MPH, ANP-BC, FAAN AACRN Endowed Professor of Nursing Leadership and Innovation Johns Hopkins University School of Nursi...
Jul 27, 2022•23 min•Ep. 70
In this podcast, Latesha Elopre, MD, MSPH discusses options for pre-exposure prophylaxis (PrEP). Listen as she explains best practices for the nonpharmacologic prevention of HIV, as well as oral and injectable pharmacologic PrEP options. Presenters: Latesha Elopre, MD, MSPH Associate Professor Division of Infectious Diseases University of Alabama at Birmingham Birmingham, Alabama Moderator Jason Farley, PhD, MPH, ANP-BC, FAAN, AACRN Endowed Professor of Nursing Leadership and Innovation Johns Ho...
Jul 27, 2022•13 min•Ep. 69
In this podcast, Latesha Elopre, MD, MSPH discusses the new CDC guideline recommendations for pre-exposure prophylaxis (PrEP). Listen as she explains the updated eligibility criteria, assessing indications for PrEP, and best practices for HIV/antibody testing. Presenter: Latesha Elopre, MD, MSPH Associate Professor Division of Infectious Diseases University of Alabama at Birmingham Birmingham, Alabama Moderator Jason Farley, PhD, MPH, ANP-BC, FAAN AACRN Endowed Professor of Nursing Leadership an...
Jul 27, 2022•8 min•Ep. 68
In this podcast, Latesha Elopre, MD, MSPH discusses inequities in pre-exposure prophylaxis (PrEP) uptake and the importance of sexual health screening. Additionally, Dr Elopre shares her best practices for receiving an adequate sexual health history from her patients. Presenters: Latesha Elopre, MD, MSPH Associate Professor Division of Infectious Diseases University of Alabama at Birmingham Birmingham, Alabama Moderator Jason Farley, PhD, MPH, ANP-BC, FAAN AACRN Endowed Professor of Nursing Lead...
Jul 27, 2022•11 min•Ep. 67
This podcast episode is part of a multimedia program discussing the co-management of moderate to severe atopic dermatitis (AD) in the primary care and specialty settings. Tune in to hear Dr Silverberg and NP Victoria Garcia-Albea highlight newly approved agents and the recent expanded labeling of an existing AD therapy, including: Ruxolitinib, a topical JAK inhibitor for mild to moderate AD approved in 2021 Abrocitinib and upadacitinib, oral JAK inhibitors approved in early 2022 for moderate to ...
Jul 19, 2022•20 min•Ep. 66
In this episode, Tycel J. Phillips, MD, and Amy Goodrich, RN, MSN, CRNP-AC, provide expert insights on key data presented at ASCO 2022 for mantle cell lymphoma regarding: Results from the phase III SHINE study of the addition of ibrutinib the first-line BR followed by rituximab maintenance in older patients with MCL Updated results from the phase II ZUMA-2 study evaluating brexucabtagene autoleucel for patients with R/R MCL Results from a phase I/II study of the ROR1 humanized monoclonal antibod...
Jun 30, 2022•24 min•Ep. 65
In this episode, John M. Burke, MD, a leading expert, and Amy Esposito, FNP-C provide expert insights on key data presented at the 2022 ASCO annual conference for CLL/SLL regarding: Updated response and safety results after 3 years of follow-up from the phase II CAPTIVATE study of ibrutinib and venetoclax in patients with previously untreated CLL Updated response and remission rates after 4 years of follow-up from a phase II trial of obinutuzumab, ibrutinib, and venetoclax in patients with eithe...
Jun 30, 2022•37 min•Ep. 64
